Melitracen and Flupentixol combination drugs banned
July 03, 2013
Gandhinagar, 3 July 2013
The Government of India has banned production, selling and distribution of all medicines having combination of Flupentixol and Melitracen. Following this, Shri H.G.Koshia, Commissioner of Food and Drugs Control, Gujarat state has in an order banned production, selling and distribution of such drugs in Gujarat and has asked distributes to return the stock to manufacturers.
Melitracen is a tricyclic antidepressant marketed in Europe and Japan by Lundbeck and Takeda, respectively, for the treatment of depression and anxiety
Flupentixol, also known as flupenthixol, marketed under brand names such as Depixol and Fluanxol, is a typical antipsychotic drug of the thioxanthene class.
Recent Stories
- Amit Shah to launch ₹1,024 crore projects in Ahmedabad during Diwali visit
- Kankaria Lakefront to Get Two Made-in-India Toy Trains
- Congress Conspiring to Create Bangladesh-Like Puppet Govt in India: Union Minister in Surat
- CNG Car Blast in Vadodara; 5 Injured as Debris Flies 200 Metres
- Kajal Baraiya Murder: Faizal Sentenced to Life Imprisonment by Bhavnagar Court
- Sakkarbaug Zoo to Exchange Four Asiatic Lions for Six Capuchin Monkeys